Medicare planning to cover at-home COVID tests starting this spring
Medicare will soon begin paying for at-home COVID tests purchased at select pharmacies and retailers, CNN reports, per the Centers for Medicare and Medicaid Services.
CMS expects said coverage will be available in early spring.
The change arrives after the Biden administration last month "began requiring health insurers to cover the cost of home tests for most Americans with private insurance," CNN writes. That said, Medicare was not included in the White House directive, angering seniors enrolled in the program.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Considering over-the-counter tests have not been covered by traditional Medicare before, the new process now being set up by CMS could take time, "which is why reimbursements won't start immediately," CNN explains.
"In the weeks ahead, we'll be working diligently on behalf of people with Medicare to set up a process for them to receive free over-the-counter tests through eligible pharmacies and other participating entities," CMS' Dr. Meena Seshamani told CNN.
The list of participating retailers and pharmacies will be released when coverage officially begins, CNN adds. Enrollees will not need to see a doctor or secure a prescription to get their free tests; they are eligible for eight tests per covered individual per month.
Until the new offering kicks in, CMS recommends Medicare enrollees order their four free at-home tests from the recently-launched government distribution progam at covidtests.gov, utilize free community testing sites, or go through a lab per their health care provider.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
The Christmas quiz 2024
From the magazine Test your grasp of current affairs and general knowledge with our quiz
By The Week UK Published
-
People of the year 2024
In the Spotlight Remember the people who hit the headlines this year?
By The Week UK Published
-
Crossword: December 25, 2024
The Week's daily crossword
By The Week Staff Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published